Ultrasound-based test to tell benign from malignant liver tumors
Part of Cancer, Digestive system clinical trials.
This study uses ultrasound images to help tell the difference between benign (non-cancerous) and malignant (cancerous) liver tumors without needing a needle biopsy. If you are 18–70, have a liver tumor visible on ultrasound, and are planning a biopsy or surgery to confirm the diagnosis, you may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 70 years old.
- You have a liver tumor that is not cancer spread from another organ.
- You have not had any previous liver treatments like surgery, ablation, radiation, chemotherapy, or a transplant.
- Your liver tumor is visible on a regular ultrasound and you will have a biopsy or surgery to confirm the diagnosis.
- Your routine clinical and ultrasound data must be collected within 7 days of the biopsy or surgery.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new ultrasound technique to catch liver cancer sooner. If you have regular imaging checks for liver cancer or are getting an MRI for a liver spot, you may be able to join.
This trial looks at whether special features seen on contrast-enhanced ultrasound can help doctors better classify liver nodules using a system called LI-RADS. It’s for people at high risk for liver cancer who have recent imaging and clear tissue diagnosis.
This study compares a shorter, non-contrast MRI and ultrasound to monitor for liver cancer in people with cirrhosis whose ultrasound images aren’t clear enough. It aims to see which method works better and may help you get safer, more reliable follow-up.
This study tests whether a special 3D ultrasound scan (using contrast) can help support decisions for people with colorectal cancer that has spread to the liver. If you have planned new cancer treatment, the scan may add information to help doctors guide care.
This study aims to improve how doctors diagnose and treat liver cancer by combining advanced imaging tests and genetic analysis. It may help in choosing the most effective treatment for each person.
This trial uses a special, high-detail ultrasound to get clearer images of liver tumors. It may help doctors better understand your tumor without extra procedures.
Hear when a new Liver Tumor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.